Palliative cancer care in Middle Eastern countries: accomplishments and challenges von Silbermann, M, Arnaout, M, Daher, M, Nestoros, S, Pitsillides, B, Charalambous, H, Gultekin, M, Fahmi, R, Mostafa, K A H, Khleif, A D, Manasrah, N, Oberman, A

Volltext

Palliative cancer care in Middle Eastern countries: accomplishments and challengest von SILBERMANN, M, ARNAOUT, M, MANASRAH, N, OBERMAN, A, DAHER, M, NESTOROS, S, PITSILLIDES, B, CHARALAMBOUS, H, GULTEKIN, M, FAHMI, R, MOSTAFA, K. A. H, KHLEIF, A. D

Volltext

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study von Zamarin, Dmitriy, Burger, Robert A, Sill, Michael W, Powell, Jr, Daniel J, Lankes, Heather A, Feldman, Michael D, Zivanovic, Oliver, Gunderson, Camille, Ko, Emily, Mathews, Cara, Sharma, Sudarshan, Hagemann, Andrea R, Khleif, Samir, Aghajanian, Carol

Volltext

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002) von Santin, Alessandro D., Deng, Wei, Frumovitz, Michael, Buza, Natalia, Bellone, Stefania, Huh, Warner, Khleif, Samir, Lankes, Heather A., Ratner, Elena S., O'Cearbhaill, Roisin E., Jazaeri, Amir A., Birrer, Michael

Volltext

MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects von Verma, Vivek, Jafarzadeh, Nazli, Boi, Shannon, Kundu, Subhadip, Jiang, Zhinuo, Fan, Yiping, Lopez, Jose, Nandre, Rahul, Zeng, Peng, Alolaqi, Fatmah, Ahmad, Shamim, Gaur, Pankaj, Barry, Simon T., Valge-Archer, Viia E., Smith, Paul D., Banchereau, Jacques, Mkrtichyan, Mikayel, Youngblood, Benjamin, Rodriguez, Paulo C., Gupta, Seema, Khleif, Samir N.

Volltext

AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development von KHLEIF, Samir N, DOROSHOW, James H, HAIT, William N

Volltext

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC von Antonia, Scott J., Balmanoukian, Ani, Brahmer, Julie, Ou, Sai-Hong I., Hellmann, Matthew D., Kim, Sang-We, Ahn, Myung-Ju, Kim, Dong-Wan, Gutierrez, Martin, Liu, Stephen V., Schöffski, Patrick, Jäger, Dirk, Jamal, Rahima, Jerusalem, Guy, Lutzky, Jose, Nemunaitis, John, Calabrò, Luana, Weiss, Jared, Gadgeel, Shirish, Bhosle, Jaishree, Ascierto, Paolo A., Rebelatto, Marlon C., Narwal, Rajesh, Liang, Meina, Xiao, Feng, Antal, Joyce, Abdullah, Shaad, Angra, Natasha, Gupta, Ashok K., Khleif, Samir N., Segal, Neil H.

Volltext

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021 von Ascierto, Paolo A, Avallone, Antonio, Bhardwaj, Nina, Bifulco, Carlo, Bracarda, Sergio, Brody, Joshua D, Buonaguro, Luigi, Demaria, Sandra, Emens, Leisha A, Ferris, Robert L, Galon, Jérôme, Khleif, Samir N, Klebanoff, Christopher A, Laskowski, Tamara, Melero, Ignacio, Paulos, Chrystal M, Pignata, Sandro, Ruella, Marco, Svane, Inge Marie, Taube, Janis M, Fox, Bernard A, Hwu, Patrick, Puzanov, Igor

Volltext

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy) von Ascierto, Paolo A, Butterfield, Lisa H, Campbell, Katie, Daniele, Bruno, Dougan, Michael, Emens, Leisha A, Formenti, Silvia, Janku, Filip, Khleif, Samir N, Kirchhoff, Tomas, Morabito, Alessandro, Najjar, Yana, Nathan, Paul, Odunsi, Kunle, Patnaik, Akash, Paulos, Chrystal M, Reinfeld, Bradley I, Skinner, Heath D, Timmerman, John, Puzanov, Igor

Volltext

Jordan Palliative Care Initiative: A WHO Demonstration Project von Stjernswärd, Jan, MD, PhD, FRCP (Edin), Ferris, Frank D., MD, Khleif, Samir N., MD, Jamous, Walid, BSc Pharmacy, MBA, Treish, Imad M., PharmD, BCOP, Milhem, Mohammed, MD, Bushnaq, Mohammed, MD, Al Khateib, Ahmad, RN, MHSA, MSc, Al Shtiat, Mohammad Nayef, MD, Wheeler, Mary S., MSN, RN, ACHPN, Alwan, Ala, MD

Volltext

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy von Gnjatic, Sacha, Bronte, Vincenzo, Brunet, Laura Rosa, Butler, Marcus O, Disis, Mary L, Galon, Jérôme, Hakansson, Leif G, Hanks, Brent A, Karanikas, Vaios, Khleif, Samir N, Kirkwood, John M, Miller, Lance D, Schendel, Dolores J, Tanneau, Isabelle, Wigginton, Jon M, Butterfield, Lisa H

Volltext

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncolo... von Santin, Alessandro D., Filiaci, Virginia, Bellone, Stefania, O’Cearbhaill, Roisin, Ratner, Elena S., Mathews, Cara A., Cantuaria, Guilherme, Gunderson, Camille C., Rutledge, Teresa, Buttin, Barbara M., Lankes, Heather A., Birrer, Michael J.

Volltext

Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort von Segal, N.H., Ou, S.-H.I., Balmanoukian, A.S., Massarelli, E., Brahmer, J.R., Weiss, J., Schoffski, P., Antonia, S.J., Massard, C., Zandberg, D.P., Maher, C., Khleif, S., Jin, X., Rebelatto, M., Steele, K., Antal, J., Gupta, A., Spreafico, A.

Volltext

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report von Mohammed, Altaf, Dashwood, Roderick H, Dickinson, Sally, Disis, Mary L, Jaffee, Elizabeth M, Johnson, Bryon D, Khleif, Samir N, Pollak, Michael N, Schlom, Jeffrey, Shoemaker, Robert H, Stanton, Sasha E, Wondrak, Georg T, You, Ming, Zhu, Hao, Miller, Mark Steven

Volltext

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art von Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Kaufman, David R, Khleif, Samir N, Wang, Ena

Volltext

514 Results of Phase 1b trial of the Indoleamine 2,3-dioxygenase (IDO) Pathway Inhibitor Indoximod plus Ipilimumab for the treatment of unresectable stage III or IV melanoma von Zakharia, Y, Drabick, J, Khleif, S, Munn, D, Link, C, Vahanian, N, Kennedy, E, Rixe, O, Milhem, M

Volltext

Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC) von Antonia, S.J., Brahmer, J.R., Khleif, S., Balmanoukian, A.S., Ou, S.-H.I., Gutierrez, M., Kim, D.-W., Kim, S.-W., Ahn, M.-J., Leach, J., Jamal, R., Jaeger, D., Jerusalem, G., Jin, X., Gupta, A., Antal, J., Segal, N.H.

Volltext

Abstract 4717: MAP kinase inhibition induces metabolic reprogramming in T-cells leading to induction of stem cell memory CD8 cells that enhance potency of adoptive cell therapy and... von Verma, Vivek, Ahmad, Shamim, Zeng, Peng, Mkrtichyan, Mikayel, Barry, Simon T., Smith, Paul D., Rodriguez, Paulo C., Janik, John E., Gupta, Seema, Khleif, Samir N.

Volltext

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015 von Ascierto, Paolo A, Agarwala, Sanjiv, Botti, Gerardo, Cesano, Alessandra, Ciliberto, Gennaro, Davies, Michael A, Demaria, Sandra, Dummer, Reinhard, Eggermont, Alexander M, Ferrone, Soldano, Fu, Yang Xin, Gajewski, Thomas F, Garbe, Claus, Huber, Veronica, Khleif, Samir, Krauthammer, Michael, Lo, Roger S, Masucci, Giuseppe, Palmieri, Giuseppe, Postow, Michael, Puzanov, Igor, Silk, Ann, Spranger, Stefani, Stroncek, David F, Tarhini, Ahmad, Taube, Janis M, Testori, Alessandro, Wang, Ena, Wargo, Jennifer A, Yee, Cassian, Zarour, Hassane, Zitvogel, Laurence, Fox, Bernard A, Mozzillo, Nicola, Marincola, Francesco M, Thurin, Magdalena

Volltext

346 Phase 1a study of the safety, pharmacokinetics, and pharmacodynamics of GDC-0919 in patients with recurrent/advanced solid tumors von Nayak, A, Hao, Z, Sadek, R, Dobbins, R, Marshall, L, Vahanian, N, Ramsey, J, Kennedy, E, Mautino, M, Link, C, Lin, R, Royer-Joo, S, Morrissey, K, Mahrus, S, McCall, B, Pirzkall, A, Munn, D, Janik, J, Khleif, S

Volltext